[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622578":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":22,"centralContacts":34,"locations":42,"responsibleParty":97,"collaborators":99,"id":126,"slug":127,"hasResults":128,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":132,"eligibilityCriteria":133,"healthyVolunteers":134,"sex":135,"minAge":10,"maxAge":10,"enrollmentInfo":136,"targetDuration":139,"studyType":140,"phases":10,"briefSummary":141,"conditions":142,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":157},{"fullName":5,"class":6},"Fundació Institut Germans Trias i Pujol","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Myotonic Dystrophy Type 1 (DM1)",null,"The group included Individuals with a confirmed genetic diagnosis of Myotonic Dystrophy Type 1 (DM1)",[13],"Other: Patient Registry",{"label":15,"type":10,"description":16,"interventionNames":17},"Control","The group included control subjects as individuals without a genetic diagnosis of Myotonic Dystrophy Type 1 (DM1).",[13],[19],{"type":6,"name":20,"description":20,"armGroupLabels":21,"otherNames":10},"Patient Registry",[15,9],[23,27,31],{"name":24,"affiliation":25,"role":26},"Gisela Nogales Gadea, Ph.D.","Germans Trias i Pujol Research Institute","STUDY_DIRECTOR",{"name":28,"affiliation":29,"role":30},"Arturo Lopez Castel, Ph.D.","INCLIVA Instituto de Investigación Sanitaria","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":33,"role":30},"Virginia Arechavala-Gomeza, Ph.D.","IIS Biobizkaia",[35,39],{"name":24,"role":36,"phone":37,"phoneExt":10,"email":38},"CONTACT","(+34) 93 554 3050","gnogales@igtp.cat",{"name":40,"role":36,"phone":10,"phoneExt":10,"email":41},"Alvaro S Larran Mottino, Ph.D.","alarran@igtp.cat",[43,55,61,67,73,79,85,91],{"facility":44,"status":45,"city":46,"state":47,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":50},"Hospitals within the DM1 network","RECRUITING","Multiple Locations","Andalusia","Spain","ES",[51,54],{"name":52,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Macarena Cabrera","dm1-hub@igtp.cat",{"name":52,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":56,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":57},"Basque Country",[58,60],{"name":59,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Andone Sistiaga",{"name":59,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":62,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":63},"Canary Islands",[64,66],{"name":65,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Jorge Alonso",{"name":65,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":68,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":69},"Cantabria",[70,72],{"name":71,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Ana Lara Pelayo",{"name":71,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":74,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":75},"Castilla-La Macha",[76,78],{"name":77,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Jorge García",{"name":77,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":80,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":81},"Catalonia",[82,84],{"name":83,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Sebastián Figueroa",{"name":83,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":86,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":87},"Madrid",[88,90],{"name":89,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Gerardo Gutiérrez",{"name":89,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":92,"zip":10,"country":48,"countryCode":49,"cosmosGeoPoint":10,"geoPoint":10,"contacts":93},"Valencia",[94,96],{"name":95,"role":36,"phone":37,"phoneExt":10,"email":53},"Dr. Nuria Muelas",{"name":95,"role":30,"phone":10,"phoneExt":10,"email":10},{"type":98,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[100,102,105,107,109,111,113,115,117,119,121,123],{"name":101,"class":6},"Instituto de Investigacion Sanitaria INCLIVA",{"name":103,"class":104},"Biobizkaia Health Research Institute","OTHER_GOV",{"name":106,"class":6},"Biogipuzkoa Health Research Institute",{"name":108,"class":6},"Germans Trias i Pujol Hospital",{"name":110,"class":6},"Hospital Infanta Sofia",{"name":112,"class":6},"Hospital de Basurto",{"name":114,"class":6},"Hospital Donostia",{"name":116,"class":6},"Hospitales Universitarios Virgen del Rocío",{"name":118,"class":6},"Hospital Universitario Marqués de Valdecilla",{"name":120,"class":6},"Complejo Hospitalario Universitario de Albacete",{"name":122,"class":6},"Hospital Universitario La Fe",{"name":124,"class":125},"Hospital Univeritario Ntra. Sra. de la Candelaria","UNKNOWN","100622578","the-spanish-national-registry-for-myotonic-dystrophy-type-1-100622578",false,"NCT07385443","The Spanish National Registry for Myotonic Dystrophy Type 1","Creación de un Nodo Integral Para la Distrofia Miotónica Tipo 1 en España: Registro clínico, Mapas genómicos, epigenómicos y proteómicos (DM1-Hub)","DM1-Hub","Inclusion Criteria:\n\n* Confirmed diagnosis of Myotonic Dystrophy Type 1 (DM1) through genetic testing.\n\nExclusion Criteria:\n\n* There are no exclusion criteria for the registry",true,"ALL",{"count":137,"type":138},3000,"ESTIMATED","10 Years","OBSERVATIONAL","Myotonic Dystrophy Type 1 (DM1) is a rare genetic neuromuscular condition that can affect multiple organs and varies widely in how it presents. DM1 is the most common form of adult-onset muscular dystrophy, with an estimated prevalence of approximately 1-5 per 10,000 people. In Spain, the condition shows notable regional differences, making it especially important to understand its characteristics within the population.\n\nThe aim of this study is to support a research initiative designed to better characterise DM1. We are developing a comprehensive national registry, collecting patient-reported information, clinical data and omics data that will improve our understanding of the disease and help identify individuals who may be eligible for clinical trials.",[143,144,145,146,147],"Myotonic Dystrophy 1","DM1","Myotonic Dystrophy Type 1","Myotonic Dystrophy, Congenital","Steinert Disease","2026-01-29",{"date":150,"type":151},"2026-02-04","ACTUAL",{"date":153,"type":151},"2025-06-02",{"date":155,"type":138},"2026-12-31",{"name":5,"class":6},8]